Trial Profile
A Randomized, Controlled Clinical Study of GB-0998 for Treatment of Generalized Myasthenia Gravis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Immunoglobulin G (Primary)
- Indications Myasthenia gravis
- Focus Therapeutic Use
- Sponsors Benesis Corporation
- 24 Dec 2014 New trial record